199 related articles for article (PubMed ID: 11477145)
41. Expression analysis of Y chromosome genes in human prostate cancer.
Dasari VK; Goharderakhshan RZ; Perinchery G; Li LC; Tanaka Y; Alonzo J; Dahiya R
J Urol; 2001 Apr; 165(4):1335-41. PubMed ID: 11257712
[TBL] [Abstract][Full Text] [Related]
42. Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.
Sørensen KD; Borre M; Ørntoft TF; Dyrskjøt L; Tørring N
Int J Cancer; 2008 Feb; 122(3):509-19. PubMed ID: 17943724
[TBL] [Abstract][Full Text] [Related]
43. Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.
Mariani S; Salvatori L; Basciani S; Arizzi M; Franco G; Petrangeli E; Spera G; Gnessi L
J Urol; 2006 Jun; 175(6):2072-7; discussion 2077. PubMed ID: 16697805
[TBL] [Abstract][Full Text] [Related]
44. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.
Kramer G; Steiner GE; Handisurya A; Stix U; Haitel A; Knerer B; Gessl A; Lee C; Marberger M
Prostate; 2002 Jun; 52(1):43-58. PubMed ID: 11992619
[TBL] [Abstract][Full Text] [Related]
45. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
46. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
[TBL] [Abstract][Full Text] [Related]
47. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
Parsons JK; Gage WR; Nelson WG; De Marzo AM
Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
[TBL] [Abstract][Full Text] [Related]
48. Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression.
Perbal B
Mol Pathol; 1999 Apr; 52(2):84-91. PubMed ID: 10474687
[TBL] [Abstract][Full Text] [Related]
49. Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.
Noble AR; Maitland NJ; Berney DM; Rumsby MG
Br J Cancer; 2018 Jan; 118(2):189-199. PubMed ID: 29136407
[TBL] [Abstract][Full Text] [Related]
50. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
51. Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src.
Scholz G; Martinerie C; Perbal B; Hanafusa H
Mol Cell Biol; 1996 Feb; 16(2):481-6. PubMed ID: 8552074
[TBL] [Abstract][Full Text] [Related]
52. Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate.
Gelmini S; Tricarico C; Petrone L; Forti G; Amorosi A; Dedola GL; Serio M; Pazzagli M; Orlando C
Clin Chem Lab Med; 2003 Mar; 41(3):261-5. PubMed ID: 12705330
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue.
Brolin J; Skoog L; Ekman P
Prostate; 1992; 20(4):281-95. PubMed ID: 1376911
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas.
Alipov G; Nakayama T; Ito M; Kawai K; Naito S; Nakashima M; Niino D; Sekine I
Histopathology; 2005 Feb; 46(2):202-8. PubMed ID: 15693893
[TBL] [Abstract][Full Text] [Related]
55. De novo steroid biosynthesis in human prostate cell lines and biopsies.
Sakai M; Martinez-Arguelles DB; Aprikian AG; Magliocco AM; Papadopoulos V
Prostate; 2016 May; 76(6):575-87. PubMed ID: 26841972
[TBL] [Abstract][Full Text] [Related]
56. Expression of the developmental and oncogenic PAX2 gene in human prostate cancer.
Khoubehi B; Kessling AM; Adshead JM; Smith GL; Smith RD; Ogden CW
J Urol; 2001 Jun; 165(6 Pt 1):2115-20. PubMed ID: 11371938
[TBL] [Abstract][Full Text] [Related]
57. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia.
Bentley H; Hamdy FC; Hart KA; Seid JM; Williams JL; Johnstone D; Russell RG
Br J Cancer; 1992 Dec; 66(6):1159-63. PubMed ID: 1280991
[TBL] [Abstract][Full Text] [Related]
58. Expression of macrophage migration inhibitory factor in the human prostate.
Meyer-Siegler K; Fattor RA; Hudson PB
Diagn Mol Pathol; 1998 Feb; 7(1):44-50. PubMed ID: 9646034
[TBL] [Abstract][Full Text] [Related]
59. Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors.
Untergasser G; Rumpold H; Hermann M; Dirnhofer S; Jilg G; Berger P
Exp Gerontol; 1999 Apr; 34(2):275-87. PubMed ID: 10363793
[TBL] [Abstract][Full Text] [Related]
60. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
